Abstract
Background: The association between stroke and menstrual factors, for example, age at the time of menarche and age at the time of menopause, has not been well studied so far and the findings are inconsistent. We sought to examine this association in Japanese postmenopausal women. Methods: We followed 1,412 postmenopausal women aged ≥35 without a history of stroke in Ohasama, Japan. Baseline data were collected using a self-administered questionnaire. Adjusted hazard ratios (HRs) and 95% CIs of each menstrual factor for stroke incidence were calculated using the Cox proportional hazard model. Results: During a median follow-up of 12.8 years, 143 participants developed a stroke for the first time. Women aged ≤13 at the time of menarche had a significantly higher probability of encountering a stroke incidence in their lives compared with women aged 15 at the time of menarche (HR 1.83; 95% CI 1.04-3.22). The same was also true for cerebral infarction (HR 2.34; 95% CI 1.18-4.66). While early menopause was not significantly associated with stroke incidence, women aged ≤45 at the time of menopause faced a higher risk for cerebral infarction compared with women aged 50 years at the time of menopause (HR 3.25; 95% CI 1.54-6.86). Conclusions: Early menarche and its associated features might be a useful tool for future intervention strategies targeting modifiable factors that trigger menstrual onset.
References
1.
Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, Howard VJ, Lichtman JH, Lisabeth LD, Piña IL, Reeves MJ, Rexrode KM, Saposnik G, Singh V, Towfighi A, Vaccarino V, Walters MR; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research: Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:1545-1588.
2.
Mehndiratta P, Wasay M, Mehndiratta MM: Implications of female sex on stroke risk factors, care, outcome and rehabilitation: an Asian perspective. Cerebrovasc Dis 2015;39:302-308.
3.
Barker-Collo S, Bennett DA, Krishnamurthi RV, Parmar P, Feigin VL, Naghavi M, Forouzanfar MH, Johnson CO, Nguyen G, Mensah GA, Vos T, Murray CJ, Roth GA; GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group: Sex differences in stroke incidence, prevalence, mortality and disability-adjusted life years: results from the Global Burden of Disease study 2013. Neuroepidemiology 2015;45:203-214.
4.
Forman MR, Mangini LD, Thelus-Jean R, Hayward MD: Life-course origins of the ages at menarche and menopause. Adolesc Health Med Ther 2013;4:1-21.
5.
Hoyt LT, Falconi AM: Puberty and perimenopause: reproductive transitions and their implications for women's health. Soc Sci Med 2015;132:103-112.
6.
Charalampopoulos D, McLoughlin A, Elks CE, Ong KK: Age at menarche and risks of all-cause and cardiovascular death: a systematic review and meta-analysis. Am J Epidemiol 2014;180:29-40.
7.
Prentice P, Viner RM: Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int J Obes (Lond) 2013;37:1036-1043.
8.
Canoy D, Beral V, Balkwill A, Wright FL, Kroll ME, Reeves GK, Green J, Cairns BJ; Million Women Study Collaborators: Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation 2015;131:237-244.
9.
Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT: Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265-279.
10.
Lisabeth L, Bushnell C: Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol 2012;11:82-91.
11.
Rocca WA, Grossardt BR, Miller VM, Shuster LT, Brown RD Jr: Premature menopause or early menopause and risk of ischemic stroke. Menopause 2012;19:272-277.
12.
Ohkubo T, Asayama K, Imai Y: The value of self-measured home blood pressure in predicting stroke. Expert Rev Neurother 2006;6:163-173.
13.
Murakami K, Tsubota-Utsugi M, Satoh M, Asayama K, Inoue R, Ishiguro A, Matsuda A, Kanno A, Yasui D, Murakami T, Metoki H, Kikuya M, Imai Y, Ohkubo T: Impaired higher-level functional capacity as a predictor of stroke in community-dwelling older adults: the Ohasama study. Stroke 2016;47:323-328.
14.
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637-676.
15.
Onland-Moret NC, Peeters PH, van Gils CH, Clavel-Chapelon F, Key T, Tjønneland A, Trichopoulou A, Kaaks R, Manjer J, Panico S, Palli D, Tehard B, Stoikidou M, Bueno-De-Mesquita HB, Boeing H, Overvad K, Lenner P, Quirós JR, Chirlaque MD, Miller AB, Khaw KT, Riboli E: Age at menarche in relation to adult height: the EPIC study. Am J Epidemiol 2005;162:623-632.
16.
Utian WH: The International Menopause Society menopause-related terminology definitions. Climacteric 1999;2:284-286.
17.
Jacobsen BK, Oda K, Knutsen SF, Fraser GE: Age at menarche, total mortality and mortality from ischaemic heart disease and stroke: the Adventist Health Study, 1976-88. Int J Epidemiol 2009;38:245-252.
18.
Wu X, Cai H, Kallianpur A, Gao YT, Yang G, Chow WH, Li HL, Zheng W, Shu XO: Age at menarche and natural menopause and number of reproductive years in association with mortality: results from a median follow-up of 11.2 years among 31,955 naturally menopausal Chinese women. PLoS One 2014;9:e103673.
19.
Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, Kondo T, Watanabe Y, Koizumi A, Inaba Y, Tamakoshi A; JACC Study Group: Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study. J Epidemiol 2006;16:177-184.
20.
Chang HS, Odongua N, Ohrr H, Sull JW, Nam CM: Reproductive risk factors for cardiovascular disease mortality among postmenopausal women in Korea: the Kangwha Cohort Study, 1985-2005. Menopause 2011;18:1205-1212.
21.
Gallagher LG, Davis LB, Ray RM, Psaty BM, Gao DL, Checkoway H, Thomas DB: Reproductive history and mortality from cardiovascular disease among women textile workers in Shanghai, China. Int J Epidemiol 2011;40:1510-1518.
22.
Mueller NT, Odegaard AO, Gross MD, Koh WP, Yuan JM, Pereira MA: Age at menarche and cardiovascular disease mortality in Singaporean Chinese women: the Singapore Chinese Health Study. Ann Epidemiol 2012;22:717-722.
23.
Merritt MA, Riboli E, Murphy N, Kadi M, Tjønneland A, Olsen A, Overvad K, Dossus L, Dartois L, Clavel-Chapelon F, Fortner RT, Katzke VA, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita HB, Peeters PH, Lund E, Nakamura A, Weiderpass E, Quirós JR, Agudo A, Molina-Montes E, Larrañaga N, Dorronsoro M, Cirera L, Barricarte A, Olsson Å, Butt S, Idahl A, Lundin E, Wareham NJ, Key TJ, Brennan P, Ferrari P, Wark PA, Norat T, Cross AJ, Gunter MJ: Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study. BMC Med 2015;13:252.
24.
Lakshman R, Forouhi NG, Sharp SJ, Luben R, Bingham SA, Khaw KT, Wareham NJ, Ong KK: Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab 2009;94:4953-4960.
25.
Yang L, Kuper H, Sandin S, Margolis KL, Chen Z, Adami HO, Weiderpass E: Reproductive history, oral contraceptive use, and the risk of ischemic and hemorrhagic stoke in a cohort study of middle-aged Swedish women. Stroke 2009;40:1050-1058.
26.
Feng Y, Hong X, Wilker E, Li Z, Zhang W, Jin D, Liu X, Zang T, Xu X, Xu X: Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Atherosclerosis 2008;196:590-597.
27.
Adair LS, Gordon-Larsen P: Maturational timing and overweight prevalence in US adolescent girls. Am J Public Health 2001;91:642-644.
28.
Lee JM, Appugliese D, Kaciroti N, Corwyn RF, Bradley RH, Lumeng JC: Weight status in young girls and the onset of puberty. Pediatrics 2007;119:e624-e630.
29.
Burt Solorzano CM, McCartney CR: Obesity and the pubertal transition in girls and boys. Reproduction 2010;140:399-410.
30.
Patton GC, Viner R: Pubertal transitions in health. Lancet 2007;369:1130-1139.
31.
Rees M: Menarche when and why? Lancet 1993;342:1375-1376.
32.
Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP: The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 2003;24:668-693.
33.
Baba Y, Ishikawa S, Amagi Y, Kayaba K, Gotoh T, Kajii E: Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause 2010;17:506-510.
34.
Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA: Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke 2009;40:1044-1049.
35.
Hahn RA, Eaker E, Rolka H: Reliability of reported age at menopause. Am J Epidemiol 1997;146:771-775.
36.
Must A, Phillips SM, Naumova EN, Blum M, Harris S, Dawson-Hughes B, Rand WM: Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol 2002;155:672-679.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
